impf-info.de
Nachdem Covid19 aus medizinischer Sicht "durch" ist, hier jetzt also wieder das Thema Impfen in ganzer Breite...
Paxlovid - Nutzen nur für Ü65 OHNE vorherige Immunität? Da dürften dann zwei Handvoll Dosen reichen als Vorrat...
Oral Nirmatrelvir and Severe Covid-19 Outcomes During the Omicron Surge | Research Square
Background Nirmatrelvir, an inhibitor of the main protease of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has demonstrated a significant decrease in the risk of progression to severe disease in symptomatic high-risk patients infected with the B.1.617.2 (delta) varian...
By accepting you will be accessing a service provided by a third-party external to https://impf-info.de/
